Skip to main content

Real-world Evidence of Duration of Adhansia XR for treatment of ADHD (RE-DAX)

Forging New Breakthroughs in ADHD Care & Treatment.

The Revive Research Institute is equipped with years of experience in investigating psychiatric conditions and being at the forefront of psychiatric therapies. We are committed to the little details from accurate data collection to managing individual patient needs during the entirety of the clinical trial.

Revive Research Institute is dedicated to providing many with a sense of normalcy in these unprecedented times, including those with mental health disorders. ADHD when not treated properly can cause many mental and physical issues that can put a strain on your relationships and mind and, the quality of life. 

To help you and many others fight this battle, the Revive Research Institute is conducting a clinical trial on an investigative medication i.e. Adhansia XR being a possible novel therapy for children and adults with ADHD (Attention Deficit Hyperactivity Disorder). 

Join us in our search for a novel therapy for ADHD.

Participation Criteria:

  • Diagnosed with ADHD (Attention Deficit Hyperactivity Disorder). 
  • Must be 12 years or older. 
  • Be willing to comply with study-related procedures. 
  • Additional Criteria may apply. 

Your participation could help with the advancement of medicine and helping children and adults alike manage & understand ADHD. Qualified research participants may receive financial compensation for their time and travel, study-related medical and psychological evaluations, and investigative study medication at no cost.

Please provide YOUR contact information only.
For more info, please visit Privacy Policy.

If you require any further information, feel free to contact us at 248-564-1485.

Close Menu

Revive Research Institute, Inc.

28270 Franklin Road
Southfield, MI

T: 248-564-1485